{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:54:39Z","timestamp":1770706479180,"version":"3.49.0"},"reference-count":37,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Previous studies have confirmed the efficacy of phosphodiesterase type 5 inhibitors (PDE-5 inhibitors) in treating diabetic erectile dysfunction (DED), but they still have research value in terms of efficacy comparison and individualized safety. This study, while evaluating safety and efficacy, also focused on the sources of heterogeneity and innovatively explored the nonlinear relationship between therapeutic effect and age.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim<\/jats:title>\n<jats:p>This study aimed to systematically evaluate the safety and efficacy of PDE-5 inhibitors for the treatment of DED and the related application effects and to provide a clinical basis for its treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>By searching PubMed, Embase, Web Of Science, Cochrane Library, China Knowledge Network (CNKI), Wipro (VIP), Wanfang, and China Biomedical Literature Database (CBM) before December 31, 2024, and reading the retrieved articles and references, PDE-5 inhibitors for diabetic erectile dysfunction in randomized controlled trials (RCTs). The literature of the included studies was evaluated using the Cochrane Literature Quality Assessment Tool. The meta-analysis was registered to PROSPERO (CRD42025637725).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Outcomes<\/jats:title>\n<jats:p>The International Index of Erectile Function (IIEF-5) overall and related evaluation questionnaires were used as the primary efficacy evaluation indicators, and adverse events were used as secondary indicators.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Meta-analysis was performed using Rever Manager 5.3 and STATA18 software. A total of 10 studies were included, and random-effects model meta-analysis analyzed the post-treatment efficacy of the 10 articles with a combined RR = 2.91, 95% CI of [1.95\u20134.34], <jats:italic>P<\/jats:italic> &lt; 0.001. Fixed-effects model meta-analysis investigated adverse effects with RR = 2.0, 95% CI of [1.53\u20132.61], <jats:italic>P<\/jats:italic> &lt; 0.001. There was a non-linear relationship between age and PDE-5 inhibitors.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>PDE-5 inhibitors can safely and effectively improve diabetic erectile dysfunction, but the degree of effectiveness of different types of drugs, the occurrence of related adverse effects, and the differences that exist between individuals still need to be taken into account during use.<\/jats:p>\n<\/jats:sec>","DOI":"10.7717\/peerj.20147","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:51:54Z","timestamp":1759827114000},"page":"e20147","source":"Crossref","is-referenced-by-count":1,"title":["The safety and efficacy of phosphodiesterase type 5 inhibitors in the treatment of diabetic erectile dysfunction: a systematic review and meta-analysis"],"prefix":"10.7717","volume":"13","author":[{"given":"Zexin","family":"Zhu","sequence":"first","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xu","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Dai","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghao","family":"Lin","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huhu","family":"Yang","sequence":"additional","affiliation":[{"name":"Guizhou Architectural Hospital, Guizhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilin","family":"Liu","sequence":"additional","affiliation":[{"name":"Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjie","family":"Bao","sequence":"additional","affiliation":[{"name":"Dalian Medical University, Dalian, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Nan","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4443","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"6","key":"10.7717\/peerj.20147\/ref-1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, intervention, comparison, outcomes and study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami","year":"2020","journal-title":"Emergency Medicine Journal: EMJ"},{"issue":"12","key":"10.7717\/peerj.20147\/ref-2","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/genes15121596","article-title":"Exploring the molecular link between diabetes and erectile dysfunction through single-cell transcriptome analysis","volume":"15","author":"Begum","year":"2024","journal-title":"Genes"},{"issue":"2","key":"10.7717\/peerj.20147\/ref-3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.urology.2004.09.056","article-title":"Efficacy, safety, and treatment satisfaction of Tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centres","volume":"65","author":"Carson","year":"2005","journal-title":"Urology"},{"issue":"16","key":"10.7717\/peerj.20147\/ref-4","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1080\/14656566.2024.2422547","article-title":"Pharmacotherapeutic strategies for the management of erectile dysfunction in patients with diabetes and pre-diabetes","volume":"25","author":"Corona","year":"2024","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"8","key":"10.7717\/peerj.20147\/ref-5","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00421-025-05734-0","article-title":"Influence of physical activity practice on sexual function in men: a systematic review","volume":"125","author":"da Silva","year":"2025","journal-title":"European Journal of Applied Physiology"},{"issue":"2","key":"10.7717\/peerj.20147\/ref-6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2164\/jandrol.111.013367","article-title":"Daily use of sildenafil improves endothelial function in men with type 2 diabetes","volume":"33","author":"Deyoung","year":"2012","journal-title":"Journal of Andrology"},{"issue":"1","key":"10.7717\/peerj.20147\/ref-7","doi-asserted-by":"publisher","first-page":"e13833","DOI":"10.1111\/and.13833","article-title":"Evaluation of daily avanafil efficacy in improving the endothelial function in Egyptian males with erectile dysfunction","volume":"53","author":"Elkamshoushi","year":"2021","journal-title":"Andrologia"},{"issue":"2","key":"10.7717\/peerj.20147\/ref-8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.pop.2019.02.006","article-title":"Erectile dysfunction","volume":"46","author":"Irwin","year":"2019","journal-title":"Primary Care"},{"issue":"1","key":"10.7717\/peerj.20147\/ref-9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1743-6109.2005.00196.x","article-title":"The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine","volume":"3","author":"Jackson","year":"2006","journal-title":"The Journal of Sexual Medicine"},{"issue":"Suppl 4","key":"10.7717\/peerj.20147\/ref-10","doi-asserted-by":"publisher","first-page":"S4034","DOI":"10.4103\/jpbs.jpbs_1395_24","article-title":"Triglyceride-Glucose index and its relationship to erectile dysfunction in subjects without heart disease","volume":"16","author":"Jayaram","year":"2024","journal-title":"Journal of Pharmacy & Bioallied Sciences"},{"issue":"1","key":"10.7717\/peerj.20147\/ref-11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/jsxmed\/qdac005","article-title":"Effect of phosphodiesterase type 5 inhibitors on major adverse cardiovascular events and overall mortality in a large nationwide cohort of men with erectile dysfunction and cardiovascular risk factors: a retrospective, observational study based on healthcare claims and national death index data","volume":"20","author":"Kloner","year":"2023","journal-title":"The Journal of Sexual Medicine"},{"issue":"12","key":"10.7717\/peerj.20147\/ref-12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2174\/1389450118666170215164747","article-title":"The phosphodiasterase 5-inhibitors (PDE-5 inhibitors) for erectile dysfunction ED: a therapeutic challenge for psychiatrists","volume":"19","author":"Koon","year":"2018","journal-title":"Current Drug Targets"},{"issue":"4","key":"10.7717\/peerj.20147\/ref-13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/JCMA.0000000000001205","article-title":"Potential beneficial impacts of tadalafil on cardiovascular diseases","volume":"88","author":"Lan","year":"2025","journal-title":"Journal of the Chinese Medical Association: JCMA"},{"issue":"1","key":"10.7717\/peerj.20147\/ref-14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13098-022-00825-w","article-title":"Effect of low-dose Tadalafil once daily on glycemic control in patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, placebo-controlled pilot study","volume":"14","author":"Lee","year":"2022","journal-title":"Diabetology & Metabolic Syndrome"},{"issue":"192","key":"10.7717\/peerj.20147\/ref-15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.24976\/Discov.Med.202537192.12","article-title":"Analysis of risk factors associated with organic erectile dysfunction in patients with type 2 diabetes mellitus and erectile dysfunction","volume":"37","author":"Lu","year":"2025","journal-title":"Discovery Medicine"},{"issue":"6","key":"10.7717\/peerj.20147\/ref-16","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1743-6109.2008.00820.x","article-title":"Vardenafil in men with stable statin therapy and dyslipidemia","volume":"5","author":"Miner","year":"2008","journal-title":"The Journal of Sexual Medicine"},{"key":"10.7717\/peerj.20147\/ref-17","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1007\/s11030-024-11016-2","article-title":"An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors","volume":"29","author":"Nemr","year":"2024","journal-title":"Molecular Diversity"},{"issue":"1","key":"10.7717\/peerj.20147\/ref-18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jama.1993.03510010089036","article-title":"Impotence. NIH consensus development panel on impotence","volume":"270","author":"NIH Consensus Conference","year":"1993","journal-title":"JAMA"},{"issue":"9","key":"10.7717\/peerj.20147\/ref-19","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1111\/j.1743-6109.2010.01926.x","article-title":"Efficacy and safety of mirodenafil in men taking antihypertensive medications","volume":"7","author":"Paick","year":"2010","journal-title":"The Journal of Sexual Medicine"},{"issue":"8","key":"10.7717\/peerj.20147\/ref-20","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1111\/j.1743-6109.2010.01888.x","article-title":"Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"7","author":"Park","year":"2010","journal-title":"The Journal of Sexual Medicine"},{"issue":"5","key":"10.7717\/peerj.20147\/ref-21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.ajem.2007.08.009","article-title":"Hyperglycemia in ED patients with no history of diabetes","volume":"26","author":"Prince","year":"2008","journal-title":"The American Journal of Emergency Medicine"},{"issue":"9","key":"10.7717\/peerj.20147\/ref-22","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_293_24","article-title":"Sexual dysfunction, depression, and marital adjustment in diabetic male patients","volume":"66","author":"Rathod","year":"2024","journal-title":"Indian Journal of Psychiatry"},{"key":"10.7717\/peerj.20147\/ref-23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1530\/EJE-15-1100","article-title":"Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial","volume":"174","author":"Santi","year":"2016","journal-title":"European Journal of Endocrinology"},{"issue":"2","key":"10.7717\/peerj.20147\/ref-24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/sj.ijir.3901491","article-title":"The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems","volume":"19","author":"Schwarz","year":"2007","journal-title":"International Journal of Impotence Research"},{"issue":"2","key":"10.7717\/peerj.20147\/ref-25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.juro.2016.05.066","article-title":"Re: six months of daily treatment with vardenafil improves parameters of endothelial inflammation and hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial","volume":"196","author":"Seftel","year":"2016","journal-title":"The Journal of Urology"},{"key":"10.7717\/peerj.20147\/ref-26","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"2","key":"10.7717\/peerj.20147\/ref-27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.eururo.2007.01.028","article-title":"Development and validation of a premature ejaculation diagnostic tool","volume":"52","author":"Symonds","year":"2007","journal-title":"European Eurology"},{"issue":"5","key":"10.7717\/peerj.20147\/ref-28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4097\/kja.21080","article-title":"Self-learning software tools for data analysis in meta-analysis","volume":"74","author":"Tantry","year":"2021","journal-title":"Korean Journal of Anesthesiology"},{"issue":"3\u20134","key":"10.7717\/peerj.20147\/ref-29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.vasdi.2025.05.003","article-title":"Erectile dysfunction: a public health issue? The need for consistent treatment","volume":"50","author":"Virag","year":"2025","journal-title":"Vascular Diseases"},{"issue":"4","key":"10.7717\/peerj.20147\/ref-30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.18388\/abp.2020_6315","article-title":"Simvastatin attenuates diabetes mellitus erectile dysfunction in rats by miR-9-5p-regulated PDCD4","volume":"70","author":"Weng","year":"2023","journal-title":"Acta Biochimica Polonica"},{"key":"10.7717\/peerj.20147\/ref-31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3969\/j.issn.1000-7377.2012.01.034","article-title":"Treatment of erectile dysfunction with tadalafil in patients with type 2 diabetes mellitus: an analysis of 90 cases","volume":"41.01","author":"Yu","year":"2012","journal-title":"Shanxi Medical Journal"},{"key":"10.7717\/peerj.20147\/ref-32","doi-asserted-by":"publisher","first-page":"1512360","DOI":"10.3389\/fendo.2025.1512360","article-title":"Animal models in the study of diabetic erectile dysfunction: mechanisms and applications","volume":"16","author":"Zhang","year":"2025","journal-title":"Frontiers in Endocrinology"},{"issue":"11","key":"10.7717\/peerj.20147\/ref-33","doi-asserted-by":"publisher","first-page":"111963","DOI":"10.1016\/j.diabres.2024.111963","article-title":"Comparing ADA and IDF diagnostic criteria for intermediate hyperglycaemia and diabetes in the SHiDS study","volume":"219","author":"Zhang","year":"2025","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"3","key":"10.7717\/peerj.20147\/ref-34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","article-title":"Global healthcare expenditure on diabetes for 2010 and 2030","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Research and Clinical Practice"},{"key":"10.7717\/peerj.20147\/ref-35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11011-024-01472-y","article-title":"Research progress on the association of insulin resistance with type 2 diabetes mellitus and Alzheimer\u2019s disease","volume":"40","author":"Zheng","year":"2024","journal-title":"Metabolic Brain Disease"},{"issue":"2","key":"10.7717\/peerj.20147\/ref-36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5114\/aoms\/188718","article-title":"Causal relationship between sleep traits and erectile dysfunction: evidence from Mendelian randomization analysis","volume":"21","author":"Zhu","year":"2024","journal-title":"Archives of Medical Science: AMS"},{"issue":"5","key":"10.7717\/peerj.20147\/ref-37","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1743-6109.2006.00295.x","article-title":"Efficacy and safety of flexible-dose Vardenafil in men with type 1 diabetes and erectile dysfunction","volume":"3","author":"Ziegler","year":"2006","journal-title":"The Journal of Sexual Medicine"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/20147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20147.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20147.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/20147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:51:56Z","timestamp":1759827116000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/20147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":37,"alternative-id":["10.7717\/peerj.20147"],"URL":"https:\/\/doi.org\/10.7717\/peerj.20147","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"article-number":"e20147"}}